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Typical atrioventricuiar (AV) nodal reentry tachy- 
cardia (AVNRT) is characterized by anterograde 
activation over a slowly conducting pathway and 
by retrograde activation through a rapidly con- 
ducting pathway. Preliminary reports suggest that 
radiofrequency catheter modification can elimi- 
nate typical AVNRT while preserving anterograde 
conduction. Radiofrequency catheter modiication 
was used to treat 66 patients with typical AVNRT. 
After baseline electrophysiologic evaluation, the 
ablation catheter was positioned proximal and su- 
perlor to the site of maximal His deflection. Radio- 
frequency energy was applied until there was sig- 
nificant attenuation of retrograde conduction, and 
elimination of AVNRT inducibility. Eighty-one pa- 
tients were successfully treated and form the ba- 
sis of this report. 
A new paroxysmal supraventricular tachycar- 
dia with RP > PR interval was induced at electro- 
physiologic testing after successful ablation in 9 
patlents (11%). Mean atrial-His activation time 
was 140 f 31 ms, and the ventriculoatrial activa- 
tion time was 170 f 46 ms. This arrhythmia was 
induced only with ventricular pacing during iso- 
proterenol infusion and appeared to be mediated 
by AV nodal reentry. New retrograde dual AV 
nodal physiology after modification was more fre- 
quent in patients with atypical tachycardia than in 
those without (4 of 9 vs 2 of 72; p <0.0001). Al- 
though none of the patients were treated, only 1 
of 9 had an episode of spontaneous atypical tachy- 
cardia during a mean follow-up of 12 months. 
Results of this study confirm that typical 
AVNRT can be rendered noninduclble without the 
complete destruction of reentrant pathways. Be- 
cause induction of “atypical” AVNRT was not pre- 
dictive of spontaneous arrhythmia recurrence, it 
should not be an indication for additional ablation 
sessions or long-term drug therapy. 
(Am J Cardiol 1992;69:503-508) 
From the Department of Internal Medicine, Division of Cardiology, 
University of Michigan Medical Center, Ann Arbor, Michigan. Manu- 
script received October 14, 1991; revised manuscript received and ac- 
cepted October 24,199 1. 
Address for reprints: Jonathan J. Langberg, MD, University of 
Michigan Medical Center, 1500 East Medical Center Drive, Bl F245, 
Ann Arbor, Michigan 48 109-0022. 
T achycardia due to atrioventricular (AV) nodal re- entry (AVNRT) needs 2 nodal or perinodal pathways, differentiated on the basis of their rel- 
ative conduction times.’ Typical AVNRT is character- 
ized by anterograde conduction over the “slow” path- 
way and by retrograde conduction over the “fast” path- 
way, and accounts for approximately 50% of patients 
with paroxysmal supraventricular tachycardia. Atypical 
AVNRT, in which there is retrograde conduction over 
the slow pathway, and anterograde conduction over the 
fast pathway, is much less frequent, accounting for 
< 1% of paroxysmal supraventricular tachycardias in 
most series.2~3 Preliminary reports suggest that cathe- 
ter modification of the AV node using radiofrequency 
energy can eliminate AVNRT while preserving antero- 
grade conduction.4-6 However, the anatomic substrate 
for nodal reentry remains incompletely defined. This re- 
port describes the occurrence of a new type of tachycar- 
dia after successful ablation of typical AVNRT. This 
tachycardia has the appearance of atypical AVNRT, 
with a PR interval shorter than the RP interval. The 
characteristics and clinical significance of this “atypi- 
cal” tachycardia, and the possible mechanisms by which 
it occurs are described. 
METHOD9 
Patients and ablative procedure: Between August 
1989 and November 1990, 88 patients (29 men and 59 
women, mean age 50 f 18 years) were referred to the 
University of Michigan Medical Center for treatment 
of typical AVNRT. This cohort was described in part in 
previous reports.4J Patients had been symptomatic for a 
mean of 18 f 13 years. The ablation procedure was 
approved by the institutional review board, and all pa- 
tients gave informed, written consent. All patients un- 
derwent a baseline electrophysiologic test to define an- 
terograde and retrograde AV conduction and refractori- 
ness, and to confirm the presence of typical AV nodal 
reentry tachycardia, using previously described tech- 
niques7 The following criteria were sought to support 
the diagnosis of AV nodal reentry: (1) tachycardia in- 
duction associated with a critical degree of prolongation 
of the atrial-His (AH) interval, and (2) atria1 activation 
during tachycardia that was coincident with or closely 
(<50 ms) followed ventricular activation. Other find- 
ings suggestive of AVNRT were the presence of dual 
AV nodal physiology (discontinuous AV nodal function 
curves) and tachycardia termination with a premature 
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TABLE I Baseline Clinical and Electrophysiologic 
Characteristics of Patients With and Without “Atypical” AVNRT 
After Catheter Ablation 
No Atypical 
Atypical AVNRT AVNRT 
After Ablation After Ablation p Value 
No. of pts. 
Mean age (yr) 
Men/women 
Duration of symptoms 
from AVNRT (yr) 
Typical AVNRT CL (ms) 
AV block CL (ms) 
VA block CL (ms) 
Anterograde dual AV 
nodal physiology 
9 
52 k 18 
l/8 
12 f 10 
314 + 40 




50 + 19 NS 
28144 NS 
18 + 14 NS 
387 + 77 0.02 
3652 79 NS 
359 + 101 NS 
51 NS 
AV block CL = atrioventricular Wenckebach block cycle length; AVNRT = 
atrioventricular nodal reentry; NS = not sgnificant; VA block CL = ventriculoatrial 
Wenckebach block cycle length. 
ventricular complex that did not result in activation of 
the atria. An electrode catheter was not introduced into 
the coronary sinus, and detailed mapping of the se- 
quence of retrograde activation was not performed. No 
patient had atypical AV nodal reentry induced before 
catheter ablation. 
The technique for catheter ablation, as previously 
described,“ was performed with an electrosurgical unit 
(Radionics RFG 3-B, Watertown, MA) that delivered a 
constant, unmodulated sine wave output at 350 kHz. A 
large-tip (3 or 4 mm in length) electrode catheter was 
positioned slightly proximal and superior to the site of 
the maximal His bundle deflection. Recordings from 
the ablation site typically had an atrial-to-ventricular 
electrogram ratio L 1, and a His amplitude <lOO pV. A 
mean of 14 f 5 W of radiofrequency power was applied 
between the distal electrode of the ablation catheter and 
an indifferent skin electrode. Ablation was continued 
until there was >50% prolongation in the PR interval or 
aVF 
ventriculoatrial conduction time, or both, and typical 
AVNRT could no longer be induced. 
Eighty-one patients had a successful outcome, de- 
fined as persistent elimination of typical AVNRT in- 
ducibility with preservation of AV conduction, and form 
the basis of this report. After a successful ablation, elec- 
trophysiologic testing was performed before and during 
isoproterenol infusion at a dose sufficient to increase the 
heart rate by 120%. Complete electrophysiologic test- 
ing with evaluation of AV conduction was repeated 2 to 
4 days and again at 3 months after the ablation proce- 
dure in all patients. At follow-up testing, patients who 
had a new supraventricular tachycardia characterized 
by an AH < the His-atria1 (HA) interval were consid- 
ered to have “atypical” tachycardia. Patients with atyp- 
ical supraventricular tachycardia induced after ablation 
had complete electrophysiologic evaluations aimed at 
characterizing the arrhythmia mechanism, including 
both atria1 and ventricular extrastimulus testing during 
tachycardia. 
Data analysis: Results are expressed as mean f 1 
standard deviation. Characteristics of patients with and 
without atypical tachycardia were compared by analysis 
of variance and chi-square analysis. The Student’s t test 
for paired data was used to compare features of supra- 
ventricular tachycardia and AV nodal function before 
and after ablation. A p value <0.05 was considered sig- 
nificant. 
RESULTS 
Nine of 8 1 (11%) patients successfully treated with 
radiofrequency catheter ablation had new, “atypical” 
AV nodal reentry induced during the follow-up electro- 
physiologic study (Figure 1). The arrhythmia was in- 
duced immediately after radiofrequency modification in 
3 patients and at the early (2 to 4 days) restudy in 4. 
Atypical tachycardia was induced for the first time at 
the late (3 months) follow-up test in 3 patients. There 
were no differences in mean age, sex distribution and 
duration of symptoms between patients with (group I) 
and without (group II) atypical AV nodal reentry after 
ablation (Table I). 
Electrophysiologic characteristics of atypical su- 
praventricular taehycardii induced during follow-up 
evaluation: In all group I patients, atypical supraven- 
tricular tachycardia was induced only by ventricular 
overdrive pacing or programmed stimulation, or both, 
during isoproterenol infusion (Figure 2). Single atypical 
echo beats were induced in only 1 patient in the baseline 
state during ventricular extrastimulation. Initiation of 
the tachycardia appeared to be dependent on achieving 
a critical degree of delay in retrograde conduction. In 4 
patients, new retrograde dual AV nodal physiology (de- 
fined as 250 ms increase in ventriculoatrial activation 
time after 10 ms decrease in the coupling interval of the 
ventricular extrastimulus) was observed after ablation 
(Figure 3). In distinct contrast to the baseline findings 
before ablation, none of these patients had supraventric- 
ular tachycardia induced with atria1 overdrive pacing or 
extrastimulation. Characteristics of the arrhythmia are 
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summarized in Table II. Mean tachycardia cycle length 
was 357 f 51 ms. Mean AH activation time was 140 f 
31 ms, and ventriculoatrial time was 170 f 46 ms. 
During ventricular pacing, retrograde conduction 
was decremental and atria1 septal activation preceded 
high right atria1 activation in all cases. Tachycardia was 
reproducibly terminated with ventricular overdrive 
pacing in 7 of 9 patients. In 1 patient, a ventricular pre- 
mature stimulus interrupted the tachycardia without 
subsequent retrograde atria1 activation, and in another, 
spontaneous termination of the arrhythmia after atria1 
activation was seen. 
AV nodal function in group 1 during isoproterenol 
infusion before and after ablation at the time of induc- 
tion of atypical AV nodal reentry are compared in Ta- 
ble II. As with the overall population, radiofrequency 
ablation produced an increase in the AH interval in si- 
nus rhythm from 69 f 12 to 147 f 26 ms. Despite the 
increase in conduction time, there was no change in an- 
terograde AV Wenckebach block cycle length. In con- 
trast, retrograde conduction was significantly attenuat- 
ed, as reflected by an increase in the ventriculoatrial 
block cycle length from 257 f 32 to 344 f 47 ms (p 
<O.Ol). The AH interval during atypical AV nodal re- 
entry was a mean of 67 ms < AH during atria1 over- 
drive pacing at a comparable cycle length of 350 ms. 
Comparison of patients with and without atypical 
atrioventricular nodal reentrant tadmycardh: The cycle 
length of AVNRT induced during the baseline electro- 
physiologic test was shorter for group I (314 f 40 ms) 
than II (387 f 77 ms; p = 0.02). Anterograde and ret- 
rograde AV nodal Wenckebach cycle lengths and the 
frequency of anterograde dual AV nodal physiology 
were the same for both groups (Table I). 
The number of radiofrequency applications, and 
the mean voltage, current and duration of each applica- 
TABLE II Changes Produced by Ablation in Nine Patients with 
New “Atypical” AVNRT 
~~ 
Characteristics of Induced AVNRT During lsoproterenol Infusion 
I Electrophysiologlc Characteristics During lsoproterenol Infusion I 
AV block CL (ms) 
VA block CL (ms) 
AH interval in sinus 
rhythm (ms) 
AH Interval during AOD 
(350 ms) 
266 r 42 257 2 32 NS 
260 + 31 344 + 47 0.01 
69 + 12 147 + 26 0.01 
118 + 62 207 k 64 0.05 
AH = atrlo-His interval; AOD = atrial overdrive pacing; CL = cycle length; VA = 
ventriculoatrial interval: other abbreviations as in Table I. 
tion were similar for the 2 groups (Table III). The am- 
plitudes of the atrial, His and ventricular electrograms 
at the site resulting in successful ablation of typical 
AVNRT were also similar for the 2 groups. 
Atrioventricular nodal function in patients with and 
without atypical reentry after successful modification 
are compared in Table IV. There were no differences in 
anterograde or retrograde block cycle lengths or effec- 
tive refractory periods between the 2 groups. Retro- 
grade conduction was present in all 9 patients in group 
I, and in 37 of 72 in group II (p = 0.0006). There was a 
trend toward shorter ventriculoatrial conduction times 
at a paced cycle length of 400 ms in group I than in II 
(162 f 10 vs 247 f 62 ms; p = 0.066). Anterograde 
dual AV nodal physiology was not seen in any group I 
patient and was present in 9 group II patients after suc- 
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TABLE 111 Ablation Parameters in Patients With and Without 
“Atypical” AVNRT 
With Atypical No Atyplcal 
AVNRT After AVNRT After 
Ablation Ablation 
Radiofrequency Energy Dellvery Parameters 
No. of RF applications 7+4 726 
Voltage (V) 42 + 6 45 + 12 
Current (amp) 0.37 + 0.044 0.35 + 0.11 
Duration (set) 49221 52 + 46 
Electrogram Amplitudes at the Effective Site 
Atrial (mV) 2.2 + .46 1.7 2 0.7 
His (mV) 0.086 + 0.082 0.066 2 0.05 
Ventricular (mV) 0.92 2 0.68 0.88 + 0.70 
AVNRT = atrioventwular nodal reentry; RF = radiofrequency energy. 
cessful modification (p = not significant). New retro- 
grade dual physiology occurred in 4 group I and in 2 
group II patients (p = 0.0001) after the procedure. 
Follow-up of patients with atypical atrioventricular 
nodal reentrant tachycardia: No patient with atypical 
AVNRT after ablation received antiarrhythmic therapy 
or additional ablation sessions. One patient developed a 
spontaneous, sustained episode of atypical AVNRT 4 
weeks after ablation. Therapy with verapamil (240 
mg/day) was initiated, but was discontinued after 2 
months because of intractable side effects. Repeat elec- 
trophysiologic testing at that time showed no retrograde 
conduction or inducible tachycardia before or during 
isoproterenol infusion. This patient has been free of ar- 
rhythmia recurrence for 13 months without therapy. 
The remaining 8 patients have been followed for 12 
f 3 months. None have had symptomatic tachycardias. 
None of the 6 patients who had atypical AVNRT dur- 
ing their initial hospitalization (either immediately after 
modification or at the early restudy) had inducible 
tachycardia at the time of late restudy (3 months). Ret- 
rograde conduction was no longer present in 3 of these 
patients during the late restudy. 
DISCUSSION 
Main findings: A new paroxysmal supraventricular 
tachycardia with a long RP interval was induced after 
successful radiofrequency catheter ablation of typical 
AVNRT in 9 of 81 (11%) patients. The baseline cycle 
length of the typical AVNRT was slightly shorter in 
patients who went on to develop atypical tachycardia 
than in those who did not. Otherwise, there were no 
differences in baseline clinical, electrophysiologic or ab- 
lation parameters between the 2 groups. 
Atypical tachycardia was inducible only by ventricu- 
lar pacing during isoproterenol infusion and appeared to 
be mediated by AV nodal reentry. New retrograde dual 
AV nodal physiology was more frequent in patients 
with atypical reentry than in those without tachycardia 
after ablation. Although no patient was treated with 
antiarrhythmic medications, only 1 of 9 had an episode 
of spontaneous atypical tachycardia during a mean fol- 
TABLE IV AV Nodal Function 2 to 4 Days After Successful 
Radiofrequency Modification (during isoproterenol infusion) 
Group I: Group II: 
Atyplcal No Atyplcal 
AVNRT AVNRT 
(n = 9) (n = 72) p Value 
AH interval in sinus 147 + 26 136 + 55 NS 
rhythm 
VA interval duringventric- 162 + 10 247 + 76 0.066 
ular pacing (CL 400 
ms) 
Maxlmal VA Interval dur- 244 239 252 k64 NS 
ing ventricular overdrive 
pacing 
AV block cycle length 257 +32 300 + 76 NS 
VA block cycle length 344*47 3492 67 NS 
AVNERP 22Ok28 236 k 43 NS 
VA ERP 263i85 269? 87 NS 
VA conduction 919 37172 0.006 
Anterograde dual physiol- o/9 9172 NS 
%Y 
Retrograde dual physiol- 419 2172 0.0001 
%!Y 
AV = atrloventrlcular; AVNERP = atnal ventricular nodal effective refractory period; 
ERP = effective refractory period; other abbreviations as m Tables I and II, 
low-up of 12 months. Therefore, induction of atypical 
AV nodal reentry after radiofrequency ablation of typi- 
cal AVNRT appears to be of little clinical significance. 
Comparison with previous studies: Several features 
of this novel arrhythmia suggest that it was mediated by 
AV nodal reentry rather than atria1 tachycardia or an 
accessory AV connection. The tachycardia was repro- 
ducibly induced with critically timed ventricular extra- 
stimulation, as has been described in patients with spon- 
taneous retrograde dual AV nodal physiology.8 Termi- 
nation of the tachycardia with a ventricular premature 
beat that did not excite the atrium excludes its partici- 
pation in the reentry circuit. Spontaneous termination 
after atria1 activation also argues against an atria1 ar- 
rhythmia. There was no evidence of extranodal accesso- 
ry AV connections, with decremental retrograde atria1 
activation in all cases. 
Haissaguerre et al9 recently described the follow-up 
of 42 patients after direct-current shock ablation for AV 
nodal reentry. Four of 26 patients (15%) undergoing 
late (4.7 f 6 months after ablation) electrophysiologic 
testing had single atypical AV nodal echo beats in- 
duced. Apparently none of these patients had sustained 
tachycardia, but it is not clear how many had repeat 
testing during isoproterenol infusion. 
Observations relating to the site of ablative injury: 
Several features of patients who developed atypical 
AVNRT may have implications relevant to the location 
of ablative injury. The AH interval during atria1 pacing 
was markedly prolonged after ablation. In contrast, the 
AH interval during atypical AVNRT was relatively 
short. The AH interval during atria1 pacing is the sum 
of conduction times in the proximal common pathway 
and the AV node itself, whereas during tachycardia, the 
AH interval is the difference between these conduction 
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times. lo Therefore, the conduction delay that was pres- 
ent during atria1 pacing was due to slowing proximal to 
the reentry circuit in the upper common pathway (Fig- 
ure 4A). This evidence of an upper common pathway 
strongly suggests that atria1 tachycardia was not respon- 
sible for the atypical tachycardia induced after ablation. 
Anterograde AV nodal block cycle length and re- 
fractoriness did not change despite the marked increase 
in conduction time. A similar pattern was observed in 
an animal study when ablative injury involved the ap- 
proaches to the node with relative sparing of the more 
distal NH region.” Some animals in that study had 
progressive attenuation of AV nodal function in the 
weeks after ablation, presumably as the result of fibrosis 
and scar formation. A similar process may account for 
the loss of retrograde conduction in 4 of 9 patients with 
atypical AV nodal reentry early after ablation. 
Possible mechanisms of atypical reentry after abfa- 
tion: Possible mechanisms for reentry after ablation are 
diagrammed in Figure 4. The arrhythmia may repre- 
sent the original, typical AV nodal reentry with super- 
imposed proximal common pathway delay. Although 
retrograde conduction in the reentry circuit remains 
fast, slow conduction in the proximal common pathway 
would produce a long ventriculoatrial interval. This 
mechanism seems unlikely because it does not account 
for the significant slowing of tachycardia rate after ab- 
lation and for the inducibility of paroxysmal supraven- 
tricular tachycardia by ventricular pacing after ablation 
but not at baseline. 
Ablative injury may have resulted in prolongation of 
refractoriness in the fast pathway. This could allow se- 
lective retrograde block in the fast pathway during ven- 
tricular pacing and initiation of atypical AVNRT (ret- 
rograde conduction through the slow pathway, and an- 
terograde over the fast pathway). The trend toward a 
shorter ventriculoatrial time at slower paced rates, and 
the emergence of retrograde dual AV nodal physiology 
in 4 of 9 patients is consistent with this hypothesis. The 
disappearance of retrograde conduction in 4 patients 
who initially had atypical tachycardia also supports the 
notion that it was mediated by a damaged fast pathway. 
FIGURE 4. Possible mechanisms of atypi- 
cal athventrkdar (AV) naalal reentry af- 
ter abletlon. A, contlnued typlcel (up fast- 
-down slow) tachycardla with superim- 
posodalblath--upper- 
pathway (UCP) delay. This proximal delay 
wodd probng retrograde atrial activation 
time. B, &lath-M increase in fast 
pathway refractori- redting in selec- 
tive retrograde fast pathway block and ini- 
tiation of %ue atypical” (up slow-down 
fast) reentry. C, slowing in retrograde fast 
pathway prodwed by dative injury 
causes increased retrograde athl activa- 
tion time and sbwing of tachycarda rate. 
Slower rate produces decrease in antero- 
grade! ventrhhr activation time. D, abla- 
tion interrupts retrograde fast pathway, 
unmasking a second, slower retrograde 
pathway. A = atrhq V = ventricle. 
An ablation-induced increase in fast pathway con- 
duction time could account for many of the observa- 
tions. Although the circuit would be the same as before 
ablation, retrograde activation would be delayed. The 
resultant slowing in tachycardia rate might be expected 
to shorten anterograde conduction time and the AH in- 
terval. 
Finally, destruction of the fast pathway might un- 
mask a third pathway capable of mediating retrograde 
conduction, albeit more slowly. Triple pathways have 
been described,i2,i3 and such a pathway may be con- 
cealed during the baseline evaluation. McGuire et alI4 
recently described a small cohort of patients with 2 
types of AV nodal reentry. In addition to typical AV 
node reentry, they also had a second type of tachycardia 
with earliest atria1 activation near the OS of the coronary 
sinus. As with the patients in the current study, the 
atypical reentry was characterized by a slower rate, 
shorter AH intervals and longer ventriculoatrial activa- 
tion time. They hypothesized that these patients had 2 
slow AV nodal pathways located posteriorly, 1 of which 
was capable of serving at the retrograde limb of a 
“slow-slow” tachycardia circuit (Figure 3B). 
This study is limited by the absence of coronary si- 
nus recordings or retrograde activation times from other 
sites on the interatrial septum. These data may have 
clarified whether the atypical reentry was mediated by 
pathways that were anatomically distinct from those re- 
sponsible for the initial, typical tachycardia. 
Clinical implications: Previous reports of patients 
treated by either catheter4-6J6 or operativei7m18 ablation 
noted control of AVNRT despite persistence of retro- 
grade AV nodal conduction, dual AV nodal physiology 
and AV nodal echo beats. The results of this study con- 
firm that typical AVNRT can be rendered noninducible 
without complete destruction of intra- or perinodal re- 
entrant pathways. 
Elimination of typical AVNRT was the end point 
for radiofrequency catheter modification of the AV 
junction in this series. More than 10% of patients 
deemed successfully treated had atypical reentry in- 
duced after ablation. Sustained tachycardia could only 
1 
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be induced during isoproterenol infusion owing to signif- 
icant attenuation of retrograde conduction. This may 
account for the low incidence of spontaneous atypical 
reentry and suggests that induction of this tachycardia 
should not be an indication for additional ablation ses- 
sions or long-term antiarrhythmic therapy. 
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